Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gregory Sullivan, MD
Tonix Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Kentucky Chandler Medical Center
Lexington, Kentucky, United States
- University of Maryland Medical Center
Baltimore, Maryland, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Wayne State University
Detroit, Michigan, United States
- Washington University
St Louis, Missouri, United States
- Baylor College of Medicine, Ben Taub Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Aug 2024
- Primary completion
- 21 Apr 2025
- Completion
- 21 Apr 2025
- Last update posted
- 24 Jun 2025
- Registered enrollment
- 3
- Registry id
- NCT06045793
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.